• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    BioOptics Stock Watch
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    Inovio Pharmaceuticals, Inc. - Common Stock (NQ:INO)

    1.870 +0.060 (+3.31%)
    Streaming Delayed Price Updated: 10:44 AM EST, Feb 24, 2026 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 1,225,294
    Open 1.810
    Bid (Size) 1.860 (900)
    Ask (Size) 1.870 (800)
    Prev. Close 1.810
    Today's Range 1.810 - 2.030
    52wk Range 1.300 - 2.979
    Shares Outstanding 210,356,896
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    News headline image
    INO Investors Have Opportunity to Lead Inovio Pharmaceuticals, Inc. Securities Fraud Lawsuit with the Schall Law Firm
    From Schall Law
    Via GlobeNewswire
    News headline image
    Is Inovio Pharmaceuticals Stock Going to $0? ↗
    This forgotten stock might be too risky even for contrarian investors. 
    Via The Motley Fool

    Performance

    YTD
    +10.7%
    +10.7%
    1 Month
    +23.8%
    +23.8%
    3 Month
    +3.3%
    +3.3%
    6 Month
    -4.1%
    -4.1%
    1 Year
    -7.4%
    -7.4%

    More News

    Read More
    News headline image
    INO Investors Have Opportunity to Lead Inovio Pharmaceuticals, Inc. Securities Fraud Lawsuit with the Schall Law Firm
    From Schall Law
    Via GlobeNewswire
    News headline image
    Deadline Alert: Inovio Pharmaceuticals, Inc. (INO) Shareholders Who Lost Money Urged To Contact Glancy Prongay Wolke & Rotter LLP About Securities Fraud Lawsuit
    From Glancy Prongay Wolke & Rotter LLP
    Via Business Wire
    News headline image
    Deadline Approaching: Inovio Pharmaceuticals, Inc. (INO) Shareholders Who Lost Money Urged To Contact Law Offices of Howard G. Smith
    From Law Offices of Howard G. Smith
    Via Business Wire
    News headline image
    INO INVESTOR NOTICE: Faruqi & Faruqi, LLP Reminds Inovio Pharmaceuticals (INO) Investors of Securities Class Action Deadline on April 7, 2026
    From Faruqi & Faruqi LLP
    Via GlobeNewswire
    News headline image
    Law Offices of Frank R. Cruz Encourages Inovio Pharmaceuticals, Inc. (INO) Shareholders To Inquire About Securities Fraud Class Action
    From Law Offices of Frank R. Cruz
    Via Business Wire
    News headline image
    Glancy Prongay Wolke & Rotter LLP, a Leading Securities Fraud Law Firm, Encourages Inovio Pharmaceuticals, Inc. (INO) Shareholders to Inquire About Securities Fraud Class Action
    From Glancy Prongay Wolke & Rotter LLP
    Via Business Wire
    News headline image
    Pomerantz Law Firm Announces the Filing of a Class Action Against Inovio Pharmaceuticals, Inc.and Certain Officers – INO
    From Pomerantz LLP
    Via GlobeNewswire
    News headline image
    INO Investors Have Opportunity to Lead Inovio Pharmaceuticals, Inc. Securities Fraud Lawsuit with the Schall Law Firm
    From Schall Law
    Via GlobeNewswire
    News headline image
    INO SHAREHOLDER ALERT: Faruqi & Faruqi, LLP Reminds Inovio Pharmaceuticals (INO) Investors of Securities Class Action Deadline on April 7, 2026
    From Faruqi & Faruqi LLP
    Via GlobeNewswire
    News headline image
    INO Investors Have Opportunity to Lead Inovio Pharmaceuticals, Inc. Securities Fraud Lawsuit with the Schall Law Firm
    From Schall Law
    Via GlobeNewswire
    News headline image
    INO Class Action Alert: Robbins LLP Reminds Investors of the Lead Plaintiff Deadline in the Inovio Pharmaceuticals, Inc. Class Action
    From Robbins LLP
    Via GlobeNewswire
    News headline image
    Law Offices of Howard G. Smith Encourages Inovio Pharmaceuticals, Inc. (INO) Shareholders To Inquire About Securities Fraud Class Action
    From Law Offices of Howard G. Smith
    Via Business Wire
    News headline image
    Securities Fraud Investigation Into Inovio Pharmaceuticals, Inc. (INO) Announced – Shareholders Who Lost Money Urged To Contact Glancy Prongay Wolke & Rotter LLP, a Leading Securities Fraud Law Firm
    From Glancy Prongay Wolke & Rotter LLP
    Via Business Wire
    News headline image
    Inovio Pharmaceuticals, Inc. (INO) Shareholders Who Lost Money – Contact Law Offices of Howard G. Smith About Securities Fraud Investigation
    From Law Offices of Howard G. Smith
    Via Business Wire
    News headline image
    Securities Fraud Investigation Into Inovio Pharmaceuticals, Inc. (INO) Announced – Shareholders Who Lost Money Urged To Contact The Law Offices of Frank R. Cruz
    From The Law Offices of Frank R. Cruz
    Via Business Wire
    News headline image
    Inovio Pharmaceuticals, Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights – INO
    From DJS Law Group
    Via Business Wire
    News headline image
    INOVIO CLASS ACTION ALERT: Bragar Eagel & Squire, P.C. Announces that a Class Action Lawsuit Has Been Filed Against Inovio Pharmaceuticals, Inc. and Encourages Investors to Contact the Firm
    From Bragar Eagel & Squire
    Via GlobeNewswire
    News headline image
    INO Investors Have Opportunity to Lead Inovio Pharmaceuticals, Inc. Securities Fraud Lawsuit with the Schall Law Firm
    From The Schall Law Firm
    Via Business Wire
    News headline image
    Rosen Law Firm Urges Inovio Pharmaceuticals, Inc. (NASDAQ: INO) Stockholders to Contact the Firm for Information About Their Rights
    From Rosen Law Firm
    Via Business Wire
    News headline image
    Investor Notice: Shareholder Rights Law Firm Robbins LLP Informs Investors of the Inovio Pharmaceuticals, Inc. Class Action Lawsuit
    From Robbins LLP
    Via Business Wire
    News headline image
    INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Inovio Pharmaceuticals, Inc. - INO
    From Pomerantz LLP
    Via GlobeNewswire
    News headline image
    *CORRECTION*INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Inovio Pharmaceuticals, Inc. - INO
    From Pomerantz LLP
    Via GlobeNewswire
    News headline image
    *CORRECTION*INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Inovio Pharmaceuticals, Inc. - INO
    From Pomerantz LLP
    Via GlobeNewswire

    Frequently Asked Questions

    Is Inovio Pharmaceuticals, Inc. - Common Stock publicly traded?
    Yes, Inovio Pharmaceuticals, Inc. - Common Stock is publicly traded.
    What exchange does Inovio Pharmaceuticals, Inc. - Common Stock trade on?
    Inovio Pharmaceuticals, Inc. - Common Stock trades on the Nasdaq Stock Market
    What is the ticker symbol for Inovio Pharmaceuticals, Inc. - Common Stock?
    The ticker symbol for Inovio Pharmaceuticals, Inc. - Common Stock is INO on the Nasdaq Stock Market
    What is the current price of Inovio Pharmaceuticals, Inc. - Common Stock?
    The current price of Inovio Pharmaceuticals, Inc. - Common Stock is 1.870
    When was Inovio Pharmaceuticals, Inc. - Common Stock last traded?
    The last trade of Inovio Pharmaceuticals, Inc. - Common Stock was at 02/24/26 10:44 AM ET
    What is the market capitalization of Inovio Pharmaceuticals, Inc. - Common Stock?
    The market capitalization of Inovio Pharmaceuticals, Inc. - Common Stock is 393.37M
    How many shares of Inovio Pharmaceuticals, Inc. - Common Stock are outstanding?
    Inovio Pharmaceuticals, Inc. - Common Stock has 393M shares outstanding.
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the Privacy Policy and Terms Of Service.
    © 2025 FinancialContent. All rights reserved.